ArticleJournal of neurology2026
Natural history of cardiac involvement in women carrying pathogenic DMD gene variants: a 7-year longitudinal study.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac involvement is increasingly recognized in women carrying pathogenic variants in the dystrophin (DMD) gene, both Duchenne and Becker-associated, but the long-term natural history of cardiac structure, function, and conduction abnormalities in this group is not well understood. We conducted a prospective 7-year follow-up study to investigate the evolution of ventricular function, myocardial fibrosis, and arrhythmias.
methods34 women with confirmed pathogenic DMD gene variants (19 predicted to cause Duchenne muscular dystrophy and 15 Becker muscular dystrophy) underwent assessments after a mean of 7 years. Evaluations included cardiac magnetic resonance imaging with late gadolinium enhancement, 24-h Holter monitoring, 12-lead electrocardiography (ECG), cardiac biomarkers, and clinical examinations.
resultsAt the group level, left ventricular ejection fraction (LVEF) remained stable over follow-up (p = 0.403). Six women had a ≥ 5% change in LVEF: three improved with treatment, and three declined by 5-8%. Fibrosis was present in 9 women at both baseline and follow-up; 3 showed visual progression, and no new cases were identified. Although the median ventricular premature contractions per hour (VPC/h) increased from 0.23/h to 6.38/h (p < 0.001), this increase is likely not clinically meaningful as age-related increases in ventricular ectopy are also seen in healthy populations, and high-burden arrhythmias-according to prespecified thresholds-remained uncommon. ECG parameters remained stable (PR, QRS, and QTc unchanged), with no new bundle-branch blocks or high-grade atrioventricular block detected. No association was observed between LVEF, VPC/h, and supraventricular premature contraction per hour over the 7-year follow-up period.
conclusionsOver 7 years, women carrying pathogenic DMD gene variants have very little or no progression of cardiac findings (LVEF, fibrosis, and arrhythmias). Given these findings, frequent routine rhythm monitoring is not indicated. Follow-up should be risk-stratified: closer for women with symptoms, baseline high-burden ectopy, reduced LVEF, or pre-existing fibrosis; others can be reviewed at extended intervals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.